← Eichor
Study identifier: NCT07498231 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

COronoary Microcirculation Analysis NETwork

Condition: Coronary Artery Disease · Microcirculation Resistance · Microcirculation; Biomarkers; Myocardial Ischemia  ·  Sponsor: Medical University of Bialystok

PhaseNA
Planned participants180
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

COMA.NET (Coronary Microcirculation Analysis Network) is a prospective, randomized, open-label, parallel-group clinical trial designed to determine whether endotype-guided pharmacotherapy is superior to standard care in improving quality of life in patients with ischemia with non-obstructive coronary arteries. Approximately 180-190 participants with objective ischemia will be randomized to either the control or the intervention group. Pharmacotherapy based on the endotype established during intracoronary assessment will be introduced in the intervention arm of the study. The primary endpoint is the change in the Seattle Angina Questionnaire (SAQ) score from baseline to 3 months. Secondary endpoints include the diagnostic accuracy of transthoracic echocardiographic coronary flow velocity reserve (CFVR), the incidence of adverse events, associations between biomarkers and coronary microvascular dysfunction (CMD), and the identification of risk factors for specific CMD endotypes. Participants will undergo invasive functional evaluation of the coronary microcirculation, measurement of echocardiographic CFVR, and analysis of selected circulating biomarkers. The study cohort will be followed up at three and six months and will include reassessment of quality of life (Seattle Angina Questionnaire, EuroQol 5-Dimensions 5-Level questionnaire, 12-item Short Form Health Survey), anxiety (Generalized Anxiety Disorder-7 score), and functional status (6-minute walk test). The study bega…

This description comes directly from the study's public registry record.

Talk to the study team

Maciej A. Poludniewski, MD, PhD  ·  +48 85-831-84-96  ·  maciej.poludniewski@umb.edu.pl

Emil J. Dąbrowski, MD, PhD  ·  +48 85-831-84-96  ·  emil.dabrowski@umb.edu.pl

Always discuss trial participation with your own doctor first.

Locations (1)

University Clinical Hospital, Department of Invasive Cardiology, Internal Medicine with CICU and Catheterization Laboratory-Uniwersytecki Szpital Kliniczny w Białymstoku, Klinika Kardiologii Inwazyjnej, Chorób Wewnętrznych z OIOK i Pracownią HemodynamikiBialystok, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07498231